Drug allergy testing and management in Waco

There is a common scenario that plays out in our office at least once a week. A patient comes in, usually referred by their primary care doctor, and when we ask about their medication allergies, they say "penicillin." We ask what happened. They pause. "I think I had a rash when I was a kid? My mom told me I was allergic." That label has followed them for twenty, thirty, sometimes forty years. They have avoided penicillin and related antibiotics their entire adult life. Their doctors have prescribed alternative antibiotics that are more expensive, have more side effects, and contribute to antibiotic resistance. And the thing is, over 90 percent of people carrying a "penicillin allergy" label can actually tolerate penicillin when properly tested. That childhood rash was probably a viral rash that happened to coincide with the antibiotic course, not an allergy at all.

Key takeaways

• Over 90 percent of people labeled "penicillin allergic" can safely take penicillin when tested, because the original reaction was not a true allergy or the allergy has resolved over time
• Carrying an incorrect penicillin allergy label leads to use of broader-spectrum, more expensive antibiotics with more side effects and greater contribution to antibiotic resistance
• Drug allergy testing for penicillin is safe, reliable, and takes about an hour in the office, with immediate results that can change your medical care going forward

Why penicillin allergy testing matters so much

Penicillin allergy is the most commonly reported drug allergy, with about 10 percent of the US population carrying the label. But research over the past two decades has consistently shown that the vast majority of these labels are inaccurate. Several reasons explain the discrepancy.

Many childhood "allergic reactions" to penicillin were actually viral exanthems: rashes caused by the viral infection being treated, not by the antibiotic. When a child with an ear infection takes amoxicillin and develops a rash two days later, the rash gets blamed on the drug. But many viral infections cause rashes, especially in children, and the timing is coincidental. Without allergy testing at the time (which is rarely done in urgent care or pediatric office settings), the assumption becomes the label. The parent tells the child they are allergic. The child grows up believing it. Every doctor they see documents it. And nobody questions it because the risk of giving penicillin to someone who might be allergic seems higher than the cost of using an alternative.

Even patients who had a genuine penicillin allergy as children may no longer be allergic. Studies show that approximately 80 percent of patients with confirmed penicillin allergy lose their sensitivity within 10 years if they are not re-exposed to the drug. The IgE antibodies that mediated the original reaction gradually decline. After two or three decades, the allergy has often resolved completely. A 40-year-old who had anaphylaxis to amoxicillin at age 5 has a very good chance of tolerating it now.

Side effects get confused with allergies. Nausea, diarrhea, stomach upset, and even non-specific rashes from antibiotics are common side effects, not allergic reactions. They do not indicate immune-mediated allergy and do not carry risk of anaphylaxis. But they frequently get documented as "allergy" in medical records because the distinction is not made at the time of the reaction.

Family history gets confused with personal history. "My mom is allergic to penicillin, so I probably am too" is not how drug allergies work. Having a family member with penicillin allergy slightly increases your statistical risk but does not mean you are allergic. Yet this self-reported family history sometimes ends up in the allergy section of a patient's chart.

The real-world consequences of a false penicillin allergy label

The downstream effects of carrying an inaccurate penicillin allergy label are significant and well-documented in medical literature.

When you carry a penicillin allergy label, your doctors cannot prescribe penicillin, amoxicillin, or (often) any cephalosporin antibiotic. These are first-line treatments for many common infections: strep throat, ear infections, sinus infections, urinary tract infections, dental infections, skin infections, and many surgical prophylaxis protocols. Instead, you receive alternative antibiotics that come with trade-offs.

Broader-spectrum antibiotics kill more bacteria than necessary, including beneficial gut flora, increasing risk of Clostridioides difficile (C. diff) colitis, a potentially dangerous intestinal infection. Fluoroquinolones (ciprofloxacin, levofloxacin), commonly prescribed as penicillin alternatives, carry FDA black box warnings for tendon rupture, peripheral neuropathy, and central nervous system effects. Vancomycin, used in surgical settings when beta-lactams cannot be given, has its own toxicity profile and contributes to the emergence of vancomycin-resistant organisms.

Studies published in journals including the BMJ and JAMA Internal Medicine have shown that patients with penicillin allergy labels have 14 percent higher rates of methicillin-resistant Staphylococcus aureus (MRSA) infection, 30 percent more C. diff infections, longer hospital stays (averaging 0.6 days longer per admission), and approximately $1,145 more in healthcare costs per antibiotic course. Over a lifetime of infections, the cumulative impact is substantial.

There is also the surgical implication. Penicillins and cephalosporins are the preferred prophylactic antibiotics before many surgeries. When a patient's chart says "penicillin allergy," the surgical team must use alternatives that are less well-studied for prophylaxis and may be less effective at preventing surgical site infections. A study of over 8,000 surgical patients found that those with penicillin allergy labels had a 50 percent higher rate of surgical site infections, likely due to suboptimal prophylactic antibiotic choices.

How penicillin allergy testing works

Penicillin allergy testing is one of the most validated and reliable drug allergy tests available. The protocol has been refined over decades and has a negative predictive value exceeding 99 percent, meaning that if you test negative, you can safely take penicillin.

Step 1: Skin prick testing

A small drop of penicillin major determinant (penicilloyl-polylysine, commercially available as Pre-Pen) and minor determinant mixture is placed on the forearm skin and a tiny prick introduces it into the outer skin layer. A positive control (histamine) and negative control (saline) are tested simultaneously to verify that the skin is responding normally. The sites are observed for 15 to 20 minutes. If a wheal (raised bump) develops at the penicillin sites, the skin prick test is positive, indicating persistent IgE-mediated penicillin allergy. If no reaction occurs, the test proceeds to step 2.

Step 2: Intradermal testing

A small volume (0.02 mL) of diluted penicillin reagent is injected into the superficial dermis of the forearm, raising a small bleb about 3 millimeters in diameter. This is more sensitive than skin prick testing because it introduces more allergen into the tissue. The injection site is observed for 15 to 20 minutes. A positive reaction (the bleb grows to more than 3 mm larger than the negative control) indicates penicillin allergy. A negative reaction makes clinically significant penicillin allergy very unlikely, and the test proceeds to step 3.

Step 3: Oral amoxicillin challenge

If both skin prick and intradermal tests are negative, an oral dose of amoxicillin (typically 250 mg) is given in the office and the patient is observed for 60 to 90 minutes. This is the final confirmation step. Amoxicillin is used because it is the most commonly prescribed penicillin-class antibiotic and is the drug most patients will need access to. If the amoxicillin is tolerated without any reaction (no rash, no hives, no itching, no throat symptoms, no gastrointestinal symptoms), the penicillin allergy label can be confidently removed from the medical record.

What if the test is positive?

Approximately 5 to 10 percent of patients tested will have a positive result, confirming genuine penicillin allergy. This is still valuable information. It confirms the allergy definitively (rather than relying on decades-old memories), quantifies the reaction type, and helps guide future antibiotic choices with certainty rather than assumption. For patients with confirmed penicillin allergy who need a penicillin-class drug for a specific infection, drug desensitization protocols are available.

How long it takes

The entire process (skin prick testing, intradermal testing, and oral challenge) takes about 90 minutes to two hours in the office. Results are available the same day. For a test that can change your antibiotic options for the rest of your life, it is a remarkably efficient investment of time.

Testing for other drug allergies

Penicillin is unique in having well-validated, commercially available skin test reagents. For most other medications, the approach to diagnosis is different and relies more heavily on clinical history and controlled drug exposure.

Graded dose challenges

For drugs without validated skin tests, graded dose challenges are the primary diagnostic tool. The patient takes small, gradually increasing doses of the suspect medication under medical observation in a controlled clinical setting. A typical protocol starts with one-tenth or one-hundredth of the therapeutic dose, then increases at 30 to 60 minute intervals through intermediate steps until a full therapeutic dose is reached. The patient is monitored throughout for any signs of allergic reaction.

If the full dose is tolerated without any reaction, the patient is not allergic to that medication at that dose. If a reaction occurs at any step (hives, rash, throat tightness, breathing changes, cardiovascular symptoms), the challenge is stopped immediately and the reaction is treated. The challenge confirms both the presence and severity of the allergy, which helps guide future decisions about that medication and related drugs.

Graded challenges are appropriate for medications where the prior reaction was mild to moderate (rash, hives, delayed rash, gastrointestinal symptoms) and the medication is needed or likely to be needed for future treatment. They are generally not performed for medications that caused severe reactions such as anaphylaxis, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), or other serious immune-mediated reactions, unless the medication is absolutely essential and no adequate alternative exists.

Drug desensitization

When a patient has a confirmed allergy to a medication that is medically necessary and no adequate alternative exists, drug desensitization is a specialized procedure that can temporarily induce tolerance. The drug is administered in very small, gradually increasing doses over several hours (typically 12 to 16 steps over 4 to 12 hours) in a hospital or closely monitored outpatient setting with resuscitation equipment immediately available.

The mechanism involves slowly activating and partially depleting mast cell mediators rather than triggering a sudden, massive degranulation. By gradually increasing the drug concentration at the cell surface, the mast cells become temporarily refractory to full activation. The result is that the patient tolerates the medication at therapeutic doses for the duration of the treatment course.

Desensitization is most commonly performed for specific clinical scenarios. Antibiotics when the specific drug is needed and alternatives are inadequate (for example, penicillin for neurosyphilis, where no alternative is equally effective). Chemotherapy agents that have caused reactions but are the best or only treatment option for the patient's cancer. Aspirin for patients who need daily aspirin therapy for cardiac protection but have aspirin-exacerbated respiratory disease or aspirin allergy.

The tolerance achieved through desensitization is temporary. It lasts only as long as the medication is being taken continuously. If the drug is stopped for more than 24 to 48 hours, the tolerance is lost and the full allergic response can return. If the medication is needed again later, the desensitization protocol must be repeated from the beginning.

Common drug allergy categories

Penicillins and cephalosporins: the cross-reactivity question

Penicillins and cephalosporins are both beta-lactam antibiotics and share a core chemical structure. For decades, the quoted cross-reactivity rate was 10 percent, meaning 10 percent of penicillin-allergic patients would also react to cephalosporins. This number came from older studies with significant methodological limitations. Current evidence, from larger and better-designed studies, puts the true cross-reactivity rate at approximately 1 to 2 percent, and it depends on which specific cephalosporin is considered.

Cross-reactivity is driven by similarity in the side chain structure, not the shared beta-lactam ring. First-generation cephalosporins (cephalexin, cefazolin) have more structural similarity to penicillins and carry slightly higher cross-reactivity risk. Later-generation cephalosporins (ceftriaxone, cefepime) have different side chains and minimal cross-reactivity with penicillin. An allergist can determine which specific cephalosporins are safe for a penicillin-allergic patient based on their allergy test results and the structural relationships between the drugs.

Sulfonamide antibiotics

Sulfa drug allergy (to sulfamethoxazole-trimethoprim, commonly known as Bactrim or Septra) is the second most commonly reported antibiotic allergy. Reactions range from mild delayed rash (the most common) to severe Stevens-Johnson syndrome and toxic epidermal necrolysis (rare but serious). Unlike penicillin, there is no validated, standardized skin test for sulfonamide allergy. The diagnosis relies on clinical history and the characteristics of the reported reaction.

An important distinction: sulfonamide antibiotic allergy does not cross-react with non-antibiotic sulfonamides such as furosemide (a diuretic), celecoxib (an anti-inflammatory), or sumatriptan (a migraine medication). These drugs contain a sulfonamide chemical group but their structures are different enough that cross-reactivity is not clinically significant. Patients with sulfa antibiotic allergy do not need to avoid these unrelated medications.

NSAIDs: allergy vs. sensitivity vs. AERD

Reactions to non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, aspirin) are common but mechanistically diverse, and the type of reaction determines which NSAIDs are safe and which must be avoided.

True IgE-mediated allergy to a single NSAID is relatively uncommon. When it occurs, the patient reacts to one specific NSAID but tolerates others. For example, a patient with true ibuprofen allergy may safely take aspirin, naproxen, and celecoxib. Skin testing for NSAIDs is limited, so diagnosis is usually based on clinical history and sometimes graded challenge with alternative NSAIDs.

Cross-reactive NSAID sensitivity is more common. These patients react to all COX-1-inhibiting NSAIDs (aspirin, ibuprofen, naproxen) but tolerate selective COX-2 inhibitors (celecoxib) and acetaminophen. The reaction is not IgE-mediated but involves altered arachidonic acid metabolism. Hives and angioedema are the typical manifestations.

Aspirin-exacerbated respiratory disease (AERD, also called Samter's triad) is a specific syndrome involving the triad of asthma, nasal polyps, and aspirin/NSAID sensitivity. Patients develop severe bronchospasm, nasal congestion, and sometimes facial flushing within hours of taking aspirin or any COX-1-inhibiting NSAID. AERD is managed with aspirin desensitization (a gradual escalation of aspirin doses over 1 to 2 days) followed by daily aspirin maintenance, which paradoxically improves both the asthma and nasal polyp disease. This desensitization is performed by allergists experienced with the protocol.

Local anesthetics

Reported allergy to local anesthetics (lidocaine, novocaine, bupivacaine) is common but true IgE-mediated allergy is extremely rare, occurring in fewer than 1 percent of reported cases. Most reactions attributed to local anesthetic allergy are actually vasovagal episodes (fainting from anxiety or needle phobia), reactions to the epinephrine mixed with the anesthetic (heart racing, tremor, anxiety), or toxic reactions from inadvertent intravascular injection.

For patients who have had a reaction during a dental or medical procedure and carry a local anesthetic "allergy" label, testing can resolve the question. Skin testing followed by a subcutaneous challenge with the local anesthetic (injecting a small amount under the skin and observing for reaction) is safe and effective. In the vast majority of cases, the test is negative and the patient can safely receive local anesthesia for future procedures, sparing them from general anesthesia for dental work or minor surgeries.

Documentation and medical records

Accurate drug allergy documentation matters enormously, both for confirming real allergies and for removing false ones.

If testing confirms that you are NOT allergic, the allergy label must be removed from every medical record where it appears: your primary care doctor's chart, your pharmacy profile, your hospital medical record, your specialist records, and any electronic health portals. Incomplete removal means a provider who accesses an outdated record will still see the allergy and prescribe accordingly. After penicillin allergy testing, we provide patients with a letter documenting the test results that they can share with all their providers.

If testing confirms that you ARE allergic, the documentation should specify the drug, the type of reaction (immediate vs. delayed, IgE-mediated vs. non-immune), the severity, and the date. Generic labels like "penicillin allergy" without reaction details are unhelpful because they do not tell the next provider whether they are dealing with a mild rash or prior anaphylaxis, which changes the decision-making entirely.

For severe drug allergies (anaphylaxis, Stevens-Johnson syndrome, DRESS), wearing a medical alert bracelet or necklace ensures that emergency medical providers are aware of the allergy even if you are unable to communicate. This is a simple, inexpensive precaution that could be lifesaving in an emergency where the standard of care would include the drug you are allergic to.

Getting tested

If you have been carrying a penicillin allergy label for years and you are not sure what the original reaction actually was, or if it was so long ago that you cannot remember the details, testing can settle the question in about an hour. The odds are strongly in your favor: over 90 percent of patients tested will be cleared to take penicillin. If you are in the 5 to 10 percent with confirmed allergy, you will have definitive documentation and guidance on safe alternatives. Either way, you leave with better information than you walked in with, and that information will affect every antibiotic decision for the rest of your life.